Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rosacea: II. Therapy.

Michelle T Pelle1, Glen H Crawford, William D James

  • 1Department of Dermatology, Boston University Medical Center, USA.

Journal of the American Academy of Dermatology
|September 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Tribute to a Master Clinician: Richard Odom.

JAMA dermatology·2026
Same author

SAA1/FPR2 signaling between keratinocytes and neutrophils sustains chronic inflammation in Sweet syndrome.

The Journal of clinical investigation·2025
Same author

Mosaic Ring 20 Syndrome: A Meta-Analysis.

Neurology. Genetics·2025
Same author

Ring 20 syndrome: A call to action.

Epilepsia·2024
Same author

Acute and recurrent pustulosis: consolidating uncommon cases of follicular pustulosis induced by UV light and other triggers.

International journal of women's dermatology·2023
Same author

Impostor syndrome throughout medical training: Looking at impostor syndrome in a new way.

JAAD international·2023

This review details rosacea treatments, focusing on a subtype-directed approach for erythematotelangiectatic rosacea, papulopustular rosacea, phymatous rosacea, and ocular rosacea. It covers topical, oral, laser, and light therapies, with evidence reviews.

Area of Science:

  • Dermatology
  • Dermatologic Therapeutics

Background:

  • Rosacea pathogenesis remains incompletely understood, yet therapeutic options are expanding.
  • Key rosacea subtypes include erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea.
  • Divergent pathogenic factors likely drive these distinct phenotypes, necessitating tailored treatment strategies.

Purpose of the Study:

  • To provide an overview of current therapeutic modalities for rosacea.
  • To discuss a subtype-directed approach to rosacea management.
  • To review evidence supporting topical, oral, laser, and light therapies for specific rosacea subtypes.

Main Methods:

  • Review of available literature on rosacea treatments.
  • Categorization of therapies based on rosacea subtypes.

Related Experiment Videos

  • Evidence-based assessment of topical, oral, laser, and light-based interventions.

    • Main Results:

    • Therapeutic options for rosacea encompass topical agents, oral medications, laser treatments, and light-based therapies.
    • Treatment efficacy varies significantly across the different rosacea subtypes.
    • A subtype-directed therapeutic strategy is recommended for optimal patient outcomes.

    Conclusions:

    • An individualized, subtype-specific approach is crucial for effective rosacea management.
    • Continued research is needed to further elucidate rosacea pathogenesis and optimize treatment regimens.
    • Clinicians should be familiar with the range of available therapies and their application to specific rosacea phenotypes.